REVOLUTION Medicines
RVMDRevolution Medicines is a publicly-traded precision oncology company dedicated to revolutionizing cancer treatment through targeted therapeutics. The company leverages advanced drug discovery capabilities to develop novel medicines for patients with limited treatment options. With a focus on precision medicine approaches, Revolution Medicines aims to transform outcomes for cancer patients through innovative therapeutic solutions.
RVMD · Stock Price
Historical price data
AI Company Overview
Revolution Medicines is a publicly-traded precision oncology company dedicated to revolutionizing cancer treatment through targeted therapeutics. The company leverages advanced drug discovery capabilities to develop novel medicines for patients with limited treatment options. With a focus on precision medicine approaches, Revolution Medicines aims to transform outcomes for cancer patients through innovative therapeutic solutions.
Technology Platform
Proprietary drug discovery platform focused on developing targeted therapies that outsmart cancer mechanisms through precision oncology approaches.
Pipeline
14| Drug | Indication | Stage | Watch |
|---|---|---|---|
| daraxonrasib | Pancreatic Cancer | Phase 3 | |
| daraxonrasib + docetaxel | NSCLC (Non-small Cell Lung Cancer) | Phase 3 | |
| RMC-6236 + Gemcitabine + nab-paclitaxel + Irinotecan + Lipos... | Pancreatic Cancer | Phase 3 | |
| RMC-6291 + RMC-6236 + Pembrolizumab + Cisplatin + Carboplati... | Non-Small Cell Lung Cancer, NSCLC | Phase 1/2 | |
| Elironrasib + Daraxonrasib | Non-Small Cell Lung Cancer (NSCLC) | Phase 1/2 |
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Operates in the competitive precision oncology space with numerous established pharmaceutical companies and specialized biotechs. Differentiation likely depends on platform capabilities and targeted approach to cancer treatment.